The company maintains a debt-to-equity ratio of 1.99 as of 2026Q1, highlighting a persistent reliance on external financing that constrains financial flexibility.
| Total Current Assets | 2B | 1.84B | 1.7B | 1.55B | 1.2B | 671.27M | 836.18M | 441.95M | 446.78M | 156.01M |
| Cash & Short-Term Investments | 428.92M | 365.65M | 335.97M | 334.26M | 208.69M | 138.77M | 343.45M | 36.08M | 110.87M | 32.5M |
| Cash Only | 408.59M | 335.41M | 235.75M | 241.13M | 208.69M | 138.77M | 343.45M | 36.08M | 110.87M | 32.5M |
| Short-Term Investments | 20.33M | 30.23M | 100.23M | 93.13M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.12B | 1.06B | 961.89M | 860.92M | 574.17M | 352.66M | 370.64M | 285.6M | 238.12M | 69.98M |
| Days Sales Outstanding | 86.21 | 87.85 | 80.05 | 81.07 | 85.48 | 66.91 | 93.7 | 75.4 | 100.92 | 35.34 |
| Inventory | 159.21M | 164.78M | 143.76M | 130.52M | 87.58M | 61.15M | 52.57M | 37.06M | 31.83M | 17.91M |
| Days Inventory Outstanding | 19.88 | 22.1 | 19.72 | 19.52 | 20.34 | 18.05 | 20.98 | 16.02 | 23.34 | 15.49 |
| Other Current Assets | 291.5M | 258.49M | 262.25M | 223.45M | 324.66M | 118.68M | 69.52M | 83.21M | 65.96M | 35.63M |
| Total Non-Current Assets | 5.69B | 5.45B | 5.38B | 6.14B | 5.4B | 2.15B | 1.81B | 1.45B | 1.29B | 541.23M |
| Property, Plant & Equipment | 2.47B | 2.4B | 2.41B | 2.71B | 2.46B | 1.35B | 1.2B | 956.71M | 794.64M | 451.2M |
| Fixed Asset Turnover | 1.86x | 1.83x | 1.82x | 1.43x | 0.99x | 1.42x | 1.20x | 1.45x | 1.08x | 1.60x |
| Goodwill | 0 | 2.7B | 1.75B | 2.07B | 1.81B | 184.96M | 197.71M | 188.07M | 193.39M | 20.59M |
| Intangible Assets | 0 | 0 | 902.6M | 1.06B | 953.03M | 325.03M | 293.18M | 243.53M | 238.19M | 27.39M |
| Long-Term Investments | 182.1M | 91.4M | 25.69M | 20.87M | 13.1M | 14.29M | 12.1M | 9.91M | 9.21M | 2.44M |
| Other Non-Current Assets | 100.35M | 26.91M | 89.57M | 110.44M | 39.88M | 163.41M | 29.63M | 51.14M | 57.95M | 39.63M |
| Total Assets | 7.69B | 7.3B | 7.08B | 7.69B | 6.59B | 2.82B | 2.65B | 1.89B | 1.74B | 697.25M |
| Asset Turnover | 0.61x | 0.60x | 0.62x | 0.50x | 0.37x | 0.68x | 0.54x | 0.73x | 0.49x | 1.04x |
| Asset Growth % | 9.3% | 3.06% | -7.92% | 16.62% | 133.52% | 6.51% | 40.17% | 8.68% | 149.58% | - |
| Total Current Liabilities | 1.84B | 1.67B | 1.95B | 1.69B | 2.85B | 698.49M | 566.75M | 589.92M | 475.57M | 254.16M |
| Accounts Payable | 1.1B | 1.05B | 931.26M | 749.35M | 512.59M | 454.1M | 351.25M | 230.31M | 224.77M | 83.38M |
| Days Payables Outstanding | 130.49 | 141.26 | 127.75 | 112.07 | 119.02 | 134.01 | 140.21 | 99.54 | 164.81 | 72.08 |
| Short-Term Debt | 400M | 345.59M | 654.23M | 385.3M | 2.04B | 29.73M | 18.44M | 182.16M | 109.84M | 71.16M |
| Deferred Revenue (Current) | 21.94M | 97.99K | 0 | 40.12M | 12.01M | 326K | 446K | 0 | 0 | 0 |
| Other Current Liabilities | 38.21M | 267.95M | 176.61M | 205.28M | 127.47M | 156.06M | 131.4M | 91.19M | 91.17M | 62.7M |
| Current Ratio | 1.09x | 1.11x | 0.88x | 0.92x | 0.42x | 0.96x | 1.48x | 0.75x | 0.94x | 0.61x |
| Quick Ratio | 1.00x | 1.01x | 0.80x | 0.84x | 0.39x | 0.87x | 1.38x | 0.69x | 0.87x | 0.54x |
| Cash Conversion Cycle | -24.4 | -31.31 | -27.98 | -11.48 | -13.21 | -49.05 | -25.53 | -8.12 | -40.56 | -21.26 |
| Total Non-Current Liabilities | 3.93B | 3.86B | 3.51B | 4.22B | 2.19B | 1.58B | 1.43B | 722.56M | 731.26M | 189.66M |
| Long-Term Debt | 3.29B | 3.22B | 2.97B | 3.38B | 1.31B | 1.32B | 1.19B | 486.99M | 544.87M | 108.74M |
| Capital Lease Obligations | 384.48M | 94.23M | 115.43M | 126.18M | 134.84M | 123.7M | 127.52M | 151.28M | 87.9M | 64.56M |
| Deferred Tax Liabilities | 887.25M | 291.06M | 0 | 495.83M | 470.16M | 53.57M | 51.15M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 257.46M | 263.01M | 431.54M | 225.04M | 277.25M | 78.9M | 62.59M | 84.29M | 98.49M | 16.36M |
| Total Liabilities | 5.77B | 5.53B | 5.46B | 5.91B | 5.04B | 2.28B | 2B | 1.31B | 1.21B | 443.82M |
| Total Debt | 3.82B | 3.66B | 3.77B | 3.92B | 3.51B | 1.49B | 1.35B | 848.23M | 747.54M | 244.71M |
| Net Debt | 3.41B | 3.32B | 3.53B | 3.68B | 3.3B | 1.35B | 1.01B | 812.15M | 636.67M | 212.22M |
| Debt / Equity | 1.99x | 2.07x | 2.32x | 2.21x | 2.25x | 2.73x | 2.08x | 1.47x | 1.40x | 0.97x |
| Debt / EBITDA | 4.42x | 4.28x | 3.90x | 5.02x | 9.21x | 7.27x | 7.40x | 3.79x | 6.09x | 2.75x |
| Net Debt / EBITDA | 3.95x | 3.89x | 3.66x | 4.71x | 8.66x | 6.59x | 5.52x | 3.63x | 5.18x | 2.38x |
| Interest Coverage | 1.38x | 1.46x | 1.38x | 0.77x | 0.77x | 0.97x | 0.68x | 3.08x | 3.53x | 2.53x |
| Total Equity | 1.92B | 1.77B | 1.62B | 1.78B | 1.56B | 545.91M | 652.07M | 578.82M | 533.34M | 253.43M |
| Equity Growth % | 42.24% | 8.83% | -8.65% | 14.02% | 185.41% | -16.28% | 12.66% | 8.53% | 110.45% | - |
| Book Value per Share | 26.37 | 58.69 | 23.99 | 40.45 | 34.59 | 11.39 | 14.44 | 13.46 | 14.29 | 6.82 |
| Total Shareholders' Equity | 1.74B | 1.6B | 1.48B | 1.47B | 1.06B | 495.82M | 600.93M | 562.28M | 517.61M | 252.07M |
| Common Stock | 17.39M | 17.39M | 17.39M | 8.82M | 236.55M | 236.55M | 236.55M | 236.55M | 236.55M | 204.36M |
| Retained Earnings | -186.07M | 414.5M | -273.53M | -366.9M | -90.98M | -45.49M | -12.62M | 17.24M | -38.17M | -58.47M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 696.45M | -40.88M | 524.78M | 1.82B | 533.37M | -81.28M | -9.04M | -77.56M | -66.81M | -69.94M |
| Minority Interest | 179.81M | 165.58M | 145.72M | 311.28M | 493.08M | 50.09M | 51.14M | 16.54M | 15.73M | 1.36M |
High leverage and integration
According to the latest quarterly filings, Auna maintains a debt-to-equity ratio of 1.99 as of 2026Q1, reflecting a persistent reliance on external financing to support its regional expansion strategy, which warrants close monitoring given the company's historical struggle to maintain consistent profitability across its cross-border clinical operations.
The company's debt load of $3.8B relative to $1.7B in equity suggests a capital structure that is heavily skewed toward debt, likely to fund the aggressive acquisition of clinical assets. This high leverage profile leaves little room for operational error, particularly if interest rate environments or currency fluctuations impact the cost of servicing these obligations.
Based on reported financial statements, Auna's balance sheet is heavily weighted toward intangible assets, with goodwill reaching $2.8B in 2026Q1, representing a significant portion of the $7.7B total asset base and highlighting the company's reliance on successful post-acquisition synergy realization to justify its current valuation.
The substantial goodwill balance indicates that a large portion of the company's asset base is derived from acquisition premiums rather than tangible clinical infrastructure. Investors should be wary of potential impairment risks if the anticipated synergies from the Mexican and Colombian expansions fail to materialize as expected.
As reported in recent balance sheet data, Auna's current ratio stands at 1.09 in 2026Q1, a marginal improvement from previous periods but still indicative of a narrow liquidity buffer that may struggle to absorb unexpected shocks in working capital requirements or sudden spikes in medical loss ratios.
While the current ratio has stabilized above parity, the company's cash position of $408.6M remains relatively thin compared to its total liabilities. This suggests that the firm is operating with limited short-term flexibility, making it highly dependent on consistent cash flow generation from its prepaid plan segment to meet immediate obligations.
Financial statements reveal that Auna's retained earnings remain in negative territory at -$186.1M as of 2026Q1, a trend that underscores the company's ongoing difficulty in generating sustained bottom-line growth despite its significant regional footprint and aggressive expansion into high-acuity healthcare markets across Latin America.
The persistent negative retained earnings suggest that the company has yet to reach a stage of mature, self-sustaining profitability. This capital structure profile implies that equity holders are effectively subsidizing the company's growth phase, which may lead to future dilution if the firm requires additional capital to stabilize its balance sheet.
Quick answers to the most common questions about buying AUNA stock.
As of 2025, Auna S.A. (AUNA) had total assets of $7.30B including $1.84B in current assets.
Auna S.A. (AUNA) carries total debt of $3.66B, offset by $365.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Auna S.A. (AUNA) has total shareholders' equity (book value) of $1.60B ($58.69 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Auna S.A. (AUNA) reported a current ratio of 1.11x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.